TNF and sarcoidosis: Biological therapiessuch as the use of anti-TNF-α agents and anti-CD20 monoclonal antibodies have been shownto be effective in some cases of severe or refractory sarcoidosis.(3) The aim of this review was to present an overview of the various types ofmusculoskeletal involvement in sarcoidosis, focusing on their diagnosis andmanagement.